Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.
Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.6%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to study downloads.SummaryDifference5%
- Check36 days agoChange DetectedSeveral key health-related resources and pages on leukemia and safety have been removed from the website.SummaryDifference0.7%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to leukemia and rare diseases, while the previous version 2.12.1 has been removed.SummaryDifference7%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference1%
Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.